Atea Pharmaceuticals Inc
NASDAQ:AVIR
Atea Pharmaceuticals Inc
NASDAQ:AVIR
Price:
4.25
USD
-3.85%
Market Closed
Market Cap:
$340.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
TransAlta Corp
TSX:TA
|
CA |
|
American Eagle Outfitters Inc
NYSE:AEO
|
US |
|
F
|
Full Circle Lithium Corp
XTSX:FCLI
|
CA |
|
InPlay Oil Corp
TSX:IPO
|
CA |
|
Visa Inc
NYSE:V
|
US |
|
C
|
Colgate-Palmolive Co
F:CPA
|
US |
|
S&T Bancorp Inc
NASDAQ:STBA
|
US |
|
A
|
Adaro Energy Indonesia TBK PT
OTC:PADEF
|
ID |
|
FirstGroup PLC
LSE:FGP
|
UK |
|
FIH Mobile Ltd
F:FW3
|
TW |
|
S
|
Shandong Dongyue Organosilicon Materials Co Ltd
SZSE:300821
|
CN |
|
V
|
Vallourec SA
PAR:VK
|
FR |
|
C
|
Canada One Mining Corp
XTSX:CONE
|
CA |
|
Mettler-Toledo International Inc
NYSE:MTD
|
US |
|
S
|
Sun Life Financial Inc
XPHS:SLF
|
CA |
|
Tesco PLC
F:TCO2
|
UK |
|
W
|
Wesfarmers Ltd
SWB:WF3
|
AU |
|
X
|
Xilio Therapeutics Inc
NASDAQ:XLO
|
US |
|
Cango Inc
NYSE:CANG
|
CN |
Wall St Price Targets
AVIR Price Targets Summary
Atea Pharmaceuticals Inc
Atea Pharmaceuticals Inc
Wall Street analysts forecast AVIR stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for AVIR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.
Lowest Forecast
Price Target
10.1
USD
138% Upside
Average Forecast
Price Target
10.2
USD
140% Upside
Highest Forecast
Price Target
10.5
USD
147% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AVIR's stock price target?
Price Target
10.2
USD
10.2
USD
According to Wall Street analysts, the average 1-year price target for AVIR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.
